about
Falciparum malaria molecular drug resistance in the Democratic Republic of Congo: a systematic reviewIncreased Risk of Group B Streptococcus Invasive Infection in HIV-Exposed but Uninfected Infants: A Review of the Evidence and Possible MechanismsMolecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.Proportion of extended-spectrum ß-lactamase-producing Enterobacteriaceae in community setting in Ngaoundere, Cameroon.Direct identification of bacteria from BacT/ALERT anaerobic positive blood cultures by MALDI-TOF MS: MALDI Sepsityper kit versus an in-house saponin method for bacterial extraction.International external quality assurance for laboratory identification and typing of Streptococcus agalactiae (Group B streptococci)High Prevalence of Plasmodium falciparum Infection in Asymptomatic Individuals from the Democratic Republic of the Congo.Investigation on possible transmission of monkeys' Plasmodium to human in a populations living in the equatorial rainforest of the Democratic republic of Congo.Assessment of pfcrt 72-76 haplotypes eight years after chloroquine withdrawal in Kinshasa, Democratic Republic of Congo.Neonatal group B streptococcal disease: from pathogenesis to preventive strategies.Group B streptococcal epidemiology and vaccine needs in developed countries.Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference.HCMV seroprevalence and associated risk factors in pregnant women, Havana City, 2007 to 2008.Diagnosis and screening for cytomegalovirus infection in pregnant women in Cuba as prognostic markers of congenital infection in newborns: 2007-2008.Detection of Aspergillus species DNA by PCR in bronchoalveolar lavage fluid.A one-year survey of Microsporum audouinii infections in Belgium: epidemiological and genotypic characterization.Group B Streptococcus and perinatal mortality.Development of a national EUCAST challenge panel for antimicrobial susceptibility testing.Fourth Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria.Molecular epidemiology of norovirus infections in symptomatic and asymptomatic children from Bobo Dioulasso, Burkina Faso.Filamentous fungi recovered from the water distribution system of a Belgian university hospital.Bordetella pertussis seroprevalence in Belgian adults aged 20-39 years, 2012.Extended-spectrum β-lactamase-producing Enterobacteriaceae in Cameroonian hospitals.Management of the neonate at risk for early-onset Group B streptococcal disease (GBS EOD): new paediatric guidelines in Belgium.Selection of resistance during sequential use of preferential antibiotic classes.Prevalence of Campylobacter among goats and retail goat meat in Congo.Is Salvage of Recently Infected Breast Implant After Breast Augmentation or Reconstruction Possible? An Experimental Study.An outbreak of Absidia corymbifera infection associated with bandage contamination in a burns unit.Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteriaSeverity of ICU-acquired pneumonia according to infectious microorganismsProspective survey of digestive tract colonization with enterobacteriaceae that produce extended-spectrum β-lactamases in intensive care unitsEpidemiological typing of extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates by pulsed-field gel electrophoresis and antibiotic susceptibility patternsTyping of nosocomial strains of Serratia marcescens: comparison of pulsed-field gel electrophoresis of macrorestriction fragments with biotyping, esterase typing and ribotypingBactericidal activity againstPseudomonas aeruginosa is acquired by cultured human monocyte-derived macrophages after uptake of myeloperoxidase
P50
Q26786140-77FDB0EA-9DFF-4940-AB5F-3BE26AA891A1Q28067423-3C627203-5814-4E08-A191-C4BBEC24D3C6Q33778751-4A532547-2BB2-4591-928F-97D71E551C1AQ34190353-5D505EEB-799E-4604-AF0D-2A3AA2153913Q34353515-73225B14-7853-44AA-BB60-01CD92AF85D1Q35066957-1AFAC5D5-B6AA-4C3F-98C2-F15C0C041EBFQ36569073-2104FA44-5FBA-47DC-8C54-F9EDC14D5213Q36823840-CC66C5AF-5161-4C27-B47A-0DB82E41D14FQ37425711-E0DCC5AF-BE2B-4CE6-91AB-5648F3DAA219Q37889398-9C740AD5-4D2E-496C-BC37-824AE9466507Q38131232-6AF7488C-21DA-44B4-9E40-8050112DDBB5Q38243879-36F4DEDC-653E-4C7F-B9F0-16EFE1FFAE03Q38953513-90C5428A-8538-40FA-8CD2-A4B3101A30E9Q39146843-F00FD95F-C129-4BC9-A4FE-412474C7F532Q39465143-49A3E333-C705-42D3-B33C-81A4F89B3E99Q40189650-590D0CAC-D757-48C0-B702-A615E76C40C8Q40240846-271427A3-C0DB-4AC7-928E-3D51E9875BA8Q40655772-E8736FB8-E02A-4B5C-8002-A2F907355B42Q42264244-A6F4C743-7942-4D5A-AA7F-AC918E3DC4C4Q42270156-49F35E19-8F2C-4969-80A9-DC4E256AAB57Q43144161-C518A498-4B52-419F-B12E-9EDC504D21F0Q45823728-5984E4AA-C143-46B5-B868-AFE7312AB7CCQ45965152-C5C67E41-1310-47CB-9731-FFB87925923EQ46315722-DB56DFEB-56BD-4708-9DFA-4C3E1F732A1EQ46820794-8C7C9018-5B34-4352-862F-343663D14209Q46933099-6BAA00C2-4BA8-4401-9DEA-EAE44080FB2AQ49835323-704692BA-749F-4559-872D-1DC58D181828Q51384069-60E51813-3CEA-4A6F-9582-20F1BB110D7EQ58799305-30DCBE2B-C2AD-4EB7-90BD-8CF6461FA92DQ59386952-DBF090D3-4746-478E-A400-126D7373739BQ59386964-4B61A052-C35B-4B67-A73A-99C1F6575E6DQ59386977-C22719C9-2D86-47BD-A0D4-741AE6094FA7Q59386984-402A679F-EFF2-4C4F-9F7C-17E2E6F50F9CQ59386988-9399499B-5B4F-46CA-836E-0D2590ED1C92
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pierrette Melin
@ast
Pierrette Melin
@en
Pierrette Melin
@es
Pierrette Melin
@nl
type
label
Pierrette Melin
@ast
Pierrette Melin
@en
Pierrette Melin
@es
Pierrette Melin
@nl
prefLabel
Pierrette Melin
@ast
Pierrette Melin
@en
Pierrette Melin
@es
Pierrette Melin
@nl
P106
P1153
7006491870
P31
P496
0000-0002-2159-5774